Studies have shown that the occurrence and development of cardiovascular diseases can be influenced by regulating cholesterol metabolism pathways.[40] For example, statin drugs (such as atorvastatin) can inhibit the activity of HMGCR, thereby reducing cholesterol synthesis, lowering LDL cholesterol levels in the blood, and reducing the risk of cardiovascular diseases. The gene discussed is HMGCR; the disease is cardiovascular disorder.